What the evidence says about cannabis for inflammatory bowel disease
Animal studies show cannabis has anti-inflammatory and anti-diarrheal properties, and human studies show symptom and quality-of-life improvements, but no study has demonstrated actual disease modification in IBD as measured by biomarkers or endoscopic healing.
Quick Facts
What This Study Found
Preclinical data demonstrate cannabinoid anti-inflammatory, antidiarrheal, and pain-limiting properties. Human studies show benefits in symptom control and quality of life, but biomarker profiles and endoscopic healing have not improved, meaning the underlying disease process appears unaffected.
Key Numbers
No specific patient counts provided. Review covered preclinical animal models, human clinical studies, and safety data across the existing literature.
How They Did This
White paper reviewing preclinical data, clinical studies, safety data, and the regulatory landscape for medical cannabis use in inflammatory bowel disease.
Why This Research Matters
IBD patients frequently ask about cannabis, and many self-medicate. The disconnect between symptom relief and disease modification is critical information for making informed decisions.
The Bigger Picture
The finding that cannabis may improve how patients feel without changing the underlying disease is important. Symptom relief matters, but hidden inflammation can still cause long-term damage.
What This Study Doesn't Tell Us
Narrative review without systematic search methodology. Federal Schedule I classification limits the quality and quantity of available research.
Questions This Raises
- ?Could specific cannabinoid formulations or doses actually modify IBD disease activity?
- ?Does symptom masking from cannabis lead patients to delay necessary medical treatment?
Trust & Context
- Key Stat:
- Symptom relief observed but no disease modification confirmed
- Evidence Grade:
- Comprehensive review of existing evidence, but the underlying studies are limited in number and quality.
- Study Age:
- 2019 white paper.
- Original Title:
- The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
- Published In:
- Inflammatory bowel diseases, 25(3), 427-435 (2019)
- Authors:
- Swaminath, Arun(3), Berlin, Eric P, Cheifetz, Adam, Hoffenberg, Ed, Kinnucan, Jami, Wingate, Laura, Buchanan, Sarah, Zmeter, Nada, Rubin, David T
- Database ID:
- RTHC-02311
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis help with inflammatory bowel disease?
Human studies show cannabis can improve symptoms and quality of life in IBD, but no study has shown it actually reduces the underlying inflammation as measured by biomarkers or endoscopy.
What effects does cannabis have on the gut in animal studies?
Animal models show cannabinoids have anti-inflammatory, antidiarrheal, and pain-reducing properties in the gut.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02311APA
Swaminath, Arun; Berlin, Eric P; Cheifetz, Adam; Hoffenberg, Ed; Kinnucan, Jami; Wingate, Laura; Buchanan, Sarah; Zmeter, Nada; Rubin, David T. (2019). The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.. Inflammatory bowel diseases, 25(3), 427-435. https://doi.org/10.1093/ibd/izy319
MLA
Swaminath, Arun, et al. "The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.." Inflammatory bowel diseases, 2019. https://doi.org/10.1093/ibd/izy319
RethinkTHC
RethinkTHC Research Database. "The Role of Cannabis in the Management of Inflammatory Bowel..." RTHC-02311. Retrieved from https://rethinkthc.com/research/swaminath-2019-the-role-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.